日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

瑞德西韦联合标准治疗与单独使用标准治疗治疗因 COVID-19 入院的患者(DisCoVeRy):一项 3 期随机、对照、开放标签试验

Ader, Florence; Bouscambert-Duchamp, Maude; Hites, Maya; Peiffer-Smadja, Nathan; Poissy, Julien; Belhadi, Drifa; Diallo, Alpha; Lê, Minh-Patrick; Peytavin, Gilles; Staub, Thérèse; Greil, Richard; Guedj, Jérémie; Paiva, Jose-Artur; Costagliola, Dominique; Yazdanpanah, Yazdan; Burdet, Charles; Mentré, France

Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19

在接受双肺移植并感染新冠病毒的患者中,通过血液透析清除瑞德西韦代谢物GS-441524

Lê, Minh Patrick; Le Hingrat, Quentin; Jaquet, Pierre; Wicky, Paul-Henri; Bunel, Vincent; Massias, Laurent; Visseaux, Benoit; Messika, Jonathan; Descamps, Diane; Mal, Hervé; Timsit, Jean-François; Peytavin, Gilles

Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity"

回复 Yan 和 Muller 的文章:“Captisol 和 GS-704277,而非 GS-441524,是瑞德西韦肾毒性的可靠介质”。

Lê, Minh Patrick; Le Beller, Christine; Le Hingrat, Quentin; Jaquet, Pierre; Wicky, Paul-Henri; Bunel, Vincent; Massias, Laurent; Visseaux, Benoit; Messika, Jonathan; Descamps, Diane; Mal, Hervé; Timsit, Jean-François; Peytavin, Gilles

Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

DisCoVeRy试验中羟氯喹治疗COVID-19感染的负荷剂量起始方案的理论依据

Lê, Minh Patrick; Peiffer-Smadja, Nathan; Guedj, Jeremie; Néant, Nadège; Mentré, France; Ader, Florence; Yazdanpanah, Yazdan; Peytavin, Gilles

Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV-infected patients

利匹韦林治疗药物监测的实用性及其与初治和既往接受过治疗的HIV感染患者队列中病毒学应答和耐药性的关系

Néant, Nadège; Lê, Minh Patrick; Bouazza, Naïm; Gattacceca, Florence; Yazdanpanah, Yazdan; Dhiver, Catherine; Bregigeon, Sylvie; Mokhtari, Saadia; Peytavin, Gilles; Tamalet, Catherine; Descamps, Diane; Lacarelle, Bruno; Solas, Caroline

Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection

Letermovir 和 Maribavir 在体外人类子叶灌注模型中的胎盘转移。宫内治疗先天性巨细胞病毒感染的新视角

Valentine Faure Bardon, Gilles Peytavin, Minh Patrick Lê, Tiffany Guilleminot, Elisabeth Elefant, Julien Stirnemann, Marianne Leruez-Ville, Yves Ville

Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models

利用离体人胎盘灌注研究和生理模型预测人类胎儿药代动力学

De Sousa Mendes, Maïlys; Hirt, Deborah; Vinot, Cécile; Valade, Elodie; Lui, Gabrielle; Pressiat, Claire; Bouazza, Naïm; Foissac, Frantz; Blanche, Stephane; Lê, Minh Patrick; Peytavin, Gilles; Treluyer, Jean-Marc; Urien, Saik; Benaboud, Sihem

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up

在转换至替诺福韦/恩曲他滨/利匹韦林治疗的队列研究中应用PCR信号和治疗药物监测:W96随访

Charpentier, Charlotte; Lê, Minh Patrick; Joly, Véronique; Visseaux, Benoit; Lariven, Sylvie; Phung, Bao; Yéni, Patrick; Yazdanpanah, Yazdan; Descamps, Diane; Peytavin, Gilles; Landman, Roland